News and Events
All Articles
2025 Pharmacy Forecast: High-Impact Drug Classes to Watch
Are Psoriasis Treatments the Next GLP-1s?
2025 Drugs to Watch: Key Medications Shaping Pharmacy Benefits
Could GLP-1s Cause Pharmacy Plan Bottom Lines to Balloon In 2025?
Balancing Cost and Care: Covering GLP-1s for Weight Management
4 Key Barriers Holding Biosimilars Back (and how to remove them)
Unlocking Pharmacy Value for Private Equity Firms
RxBenefits, Inc. Appoints Robert Gamble Chief Executive Officer
How To Break Through the Barriers Facing Biosimilars
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
